60 day FRN

24476

Federal Register / Vol. 83, No. 103 / Tuesday, May 29, 2018 / Notices

1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
Applied Research to Address
Emerging Public Health Priorities—New
ICR—National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
On March 26, 2018, CDC issued a
Broad Agency Announcement (FY2018–
OADS–01) available at https://
www.fbo.gov/spg/HHS/CDCP/PGOA/
FY2018-OADS-BAA/listing.html. There

8. Approaches to Prevention and
Control of Parasitic Infections and
Neglected Tropical Diseases Globally
9. Surveillance and Control of
Arthropod Vectors of Human
Pathogens
10. Modernization of the Surveillance
Data Platform

is potential for standardized information
collection attached to a limited number
of awarded projects. For those projects,
a 30-day notice will be published in the
Federal Register and information
collection requests will be submitted to
OMB for approval. This Federal
Register notice is intended to broadly
inform the public of CDC’s intent to
contract with researchers to carry out a
variety of different research projects
awarded through this announcement.
For this announcement, CDC has
identified the following research areas
of interest. Interested parties are invited
to consider innovative approaches to
support advanced research and
development strategies in the following
research areas of interest:
1. New Diagnostic, Sequencing, and
Metagenomic Tools for AR Detection
and Improved Antibiotic Use
2. International Transmission,
Colonization, and Prevention of AR
Pathogens
3. Domestic Transmission, Colonization,
and Prevention of AR Pathogens and
CDI
4. Develop Human Microbiome
Disruption Indices Relevant to
Antibiotic Resistance
5. Antibiotic Resistant Pathogens and
Genes in Water Systems and the
Environment and their Contribution
to Human Infections
6. Improving Antibiotic Stewardship
7. Approaches to Prevention and
Control of Parasitic Infections in the
United States

Contracts that are awarded based on
responses to this BAA are as a result of
full and open competition and therefore
in full compliance with the provisions
of Public Law 98–369, ‘‘The
Competition in Contracting Act of
1984.’’ CDC contracts with educational
institutions, nonprofit organizations,
state and local government, and private
industry for research and development
(R&D) in those areas covered in this
BAA.
The public is invited to look at the
BAA online for greater detail and more
specific research areas falling under the
ten topics listed above.
Authorizing legislation comes from
Section 301 of the Public Health Service
Act. Responses will be voluntary and it
is not expected that there will be any
cost to respondents other than the time
to participate in information collection.
The total estimated burden for all of the
information collections is not expected
to exceed 1,500 hours (100 hours of
burden for a maximum of 15 potentially
PRA-applicable contracts).

ESTIMATED ANNUALIZED BURDEN HOURS
Average
burden per
response
(in hours)

Number of
responses per
respondent

Total burden
(in hours)

Form name

Public ................................................

Information collection .......................

150

10

1

1,500

Total ...........................................

...........................................................

........................

........................

........................

1,500

Jeffery M. Zirger,
Acting Chief, Information Collection Review
Office, Office of Scientific Integrity, Office
of the Associate Director for Science, Office
of the Director, Centers for Disease Control
and Prevention.

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

[FR Doc. 2018–11400 Filed 5–25–18; 8:45 am]

[60Day–18–1102; Docket No. CDC–2018–
0049]

BILLING CODE 4163–18–P

daltland on DSKBBV9HB2PROD with NOTICES

Number of
respondents

Type of respondents

Centers for Disease Control and
Prevention

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).

AGENCY:

ACTION:

VerDate Sep<11>2014

16:39 May 25, 2018

Jkt 244001

PO 00000

Notice with comment period.

Frm 00020

Fmt 4703

Sfmt 4703

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled Information Collection for
Tuberculosis Data from Panel
Physicians, which collects TB data
gathered during overseas immigration
medical exams.

SUMMARY:

E:\FR\FM\29MYN1.SGM

29MYN1

Federal Register / Vol. 83, No. 103 / Tuesday, May 29, 2018 / Notices
CDC must receive written
comments on or before July 30, 2018.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2018–
0049 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffery M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
DATES:

Please note: Submit all comments through
the Federal eRulemaking portal
regulations.gov) or by U.S. mail to the
address listed above.

To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffery M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;

daltland on DSKBBV9HB2PROD with NOTICES

FOR FURTHER INFORMATION CONTACT:

VerDate Sep<11>2014

16:39 May 25, 2018

Jkt 244001

2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
Information Collection for
Tuberculosis Data from Panel
Physicians—Revision—National Center
for Emerging and Zoonotic Infectious
Diseases (NCEZID), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and
Prevention’s (CDC), National Center for
Emerging and Zoonotic Infectious
Diseases (NCEZID), Division of Global
Migration and Quarantine (DGMQ),
Immigrant, Refugee, and Migrant Health
Branch (IRMH), requests approval for a
revision of an existing information
collection. This project pertains to
collecting annual reports on certain
tuberculosis data from U.S. panel
physicians.
The respondents are panel physicians.
More than 760 panel physicians from
336 panel sites perform overseas predeparture medical examinations in
accordance with requirements, referred
to as technical instructions, provided by
DGMQs Quality Assessment Program
(QAP). The role of QAP is to assist and
guide panel physicians in the
implementation of the Technical
Instructions; evaluate the quality of the
overseas medical examination for U.S.bound immigrants and refugees; assess
potential panel physician sites; and
provide recommendations to the U.S.
Department of State in matters of
immigrant medical screening.
To achieve DGMQ’s mission, the
Immigrant, Refugee and Migrant Health
branch (IRMH) works with domestic
and international programs to improve
the health of U.S.-bound immigrants

PO 00000

Frm 00021

Fmt 4703

Sfmt 4703

24477

and refugees to protect the U.S. public
by preventing the importation of
infectious disease. These goals are
accomplished through IRMH’s oversight
of medical exams required for all U.S.bound immigrants and refugees who
seek permanent residence in the U.S.
IRMH is responsible for assisting and
training the international panel
physicians with the implementation of
medical exam Technical Instructions
(TI). Technical Instructions are detailed
requirements and national policies
regarding the medical screening and
treatment of all U.S.-bound immigrants
and refugees.
Screening for tuberculosis (TB) is a
particularly important component of the
immigration medical exam and allows
panel physicians to diagnose active TB
disease prior to arrival in the United
States. As part of the Technical
Instructions requirements, panel
physicians perform chest x-rays and
laboratory tests that aid in the
identification of tuberculosis infection
(Class B1 applicants) and diagnosis of
active tuberculosis disease (Class A,
inadmissible applicants). CDC uses
these classifications to report new
immigrant and refugee arrivals with a
higher risk of developing TB disease to
U.S. state and local health departments
for further follow-up. Some information
that panel physicians collect as part of
the medical exam is not reported on the
standard Department of State forms (DSforms), thereby preventing CDC from
evaluating TB trends in globally mobile
populations and monitoring program
effectiveness.
Currently, CDC is requesting this data
be sent by panel physicians once per
year. The consequences of reducing this
frequency would be the loss of
monitoring program impact and TB
burdens in mobile populations and
immigrants and refugees coming to the
United States on an annual basis. The
total hours requested is 1,008. There is
no cost to the respondents other than
their time.
Estimated annual burden is being
reduced by 1,640 hours per year. The
number of respondents is being reduced
by 17. Reductions are due to revised
estimates on burden time per response,
and the removal of four variables from
the data collection form and improved
IT capacity at most panel sites.

E:\FR\FM\29MYN1.SGM

29MYN1

24478

Federal Register / Vol. 83, No. 103 / Tuesday, May 29, 2018 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Total burden
(in hours)

Form name

International panel physicians ..........

TB Indicators Excel Spreadsheet ....

336

1

3

1,008

Total ...........................................

...........................................................

........................

........................

........................

1,008

Jeffery M. Zirger,
Acting Chief, Information Collection Review
Office, Office of Scientific Integrity, Office
of the Associate Director for Science, Office
of the Director, Centers for Disease Control
and Prevention.
[FR Doc. 2018–11401 Filed 5–25–18; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

[60Day–18–18AAE; Docket No. CDC–2018–
0039]

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled National HIV Behavioral
Surveillance among Transgender
women (NHBS-Trans). CDC is
requesting a new 2-year approval to
pilot collecting standardized HIVrelated behavioral data from transgender
women at risk for HIV systematically
selected from 9 Metropolitan Statistical
Areas (MSAs) throughout the United
States.

SUMMARY:

CDC must receive written
comments on or before July 30, 2018.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2018–
0039 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
DATES:

VerDate Sep<11>2014

16:39 May 25, 2018

Jkt 244001

• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments through
the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.

Centers for Disease Control and
Prevention

daltland on DSKBBV9HB2PROD with NOTICES

Average
burden per
response
(in hours)

Number of
responses per
respondent

Number of
respondents

Type of respondents

To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Leroy A.
Richardson, Information Collection
Review Office, Centers for Disease
Control and Prevention, 1600 Clifton
Road NE, MS–D74, Atlanta, Georgia
30329; phone: 404–639–7570; Email:
omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
FOR FURTHER INFORMATION CONTACT:

PO 00000

Frm 00022

Fmt 4703

Sfmt 4703

including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
National HIV Behavioral Surveillance
System—among Transgender women
(NHBS-Trans)—New—National Center
for HIV/AIDS, Viral Hepatitis, STD, and
TB Prevention (NCHHSTP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The purpose of this data collection is
to monitor behaviors related to Human
Immunodeficiency Virus (HIV)
transmission and prevention in the
United States of transgender women,
who are known to be at high risk for
HIV infection, and to assess barriers to,
and best strategies for, conducting biobehavioral surveys among minority
transgender women in nine cities. This
includes recruiting, interviewing and
providing HIV testing and referral to
services (as needed) following CDC
protocol based on an existing HIV
Behavioral Surveillance system. The
proposed respondents are 200 adult
minority trangender women in each of
nine cities (1,800 interviews total) who
will each respond one time over the
course of the two year pilot. The
information will be collected over a two
year period beginning no later than two
months after OMB approval.
NHBS-Trans provides information to
help prevent HIV among transgender
women. Preventing HIV, especially
among high-risk groups, is an effective
strategy for reducing individual, local,
and national healthcare costs. The
utility of this information is to provide
CDC and local health department staff
with data for evaluating progress
towards local and national public health

E:\FR\FM\29MYN1.SGM

29MYN1